Unknown

Dataset Information

0

Tumor expression of adiponectin receptor 2 and lethal prostate cancer.


ABSTRACT: To investigate the role of adiponectin receptor 2 (AdipoR2) in aggressive prostate cancer we used immunohistochemistry to characterize AdipoR2 protein expression in tumor tissue for 866 men with prostate cancer from the Physicians' Health Study and the Health Professionals Follow-up Study. AdipoR2 tumor expression was not associated with measures of obesity, pathological tumor stage or prostate-specific antigen (PSA) at diagnosis. However, AdipoR2 expression was positively associated with proliferation as measured by Ki-67 expression quartiles (P-trend < 0.0001), with expression of fatty acid synthase (P-trend = 0.001), and with two measures of angiogenesis (P-trend < 0.1). An inverse association was observed with apoptosis as assessed by the TUNEL assay (P-trend = 0.006). Using Cox proportional hazards regression and controlling for age at diagnosis, Gleason score, year of diagnosis category, cohort and baseline BMI, we identified a statistically significant trend for the association between quartile of AdipoR2 expression and lethal prostate cancer (P-trend = 0.02). The hazard ratio for lethal prostate cancer for the two highest quartiles, as compared to the two lowest quartiles, of AdipoR2 expression was 1.9 (95% confidence interval [CI]: 1.2-3.0). Results were similar when additionally controlling for categories of PSA at diagnosis and Ki-67 expression quartiles. These results strengthen the evidence for the role of AdipoR2 in prostate cancer progression.

SUBMITTER: Rider JR 

PROVIDER: S-EPMC4481603 | biostudies-literature | 2015 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications


To investigate the role of adiponectin receptor 2 (AdipoR2) in aggressive prostate cancer we used immunohistochemistry to characterize AdipoR2 protein expression in tumor tissue for 866 men with prostate cancer from the Physicians' Health Study and the Health Professionals Follow-up Study. AdipoR2 tumor expression was not associated with measures of obesity, pathological tumor stage or prostate-specific antigen (PSA) at diagnosis. However, AdipoR2 expression was positively associated with prolif  ...[more]

Similar Datasets

| S-EPMC4422178 | biostudies-other
| S-EPMC3049266 | biostudies-literature
| S-EPMC6532645 | biostudies-literature
| S-EPMC6494092 | biostudies-literature
| S-EPMC3700351 | biostudies-literature
| S-EPMC3107752 | biostudies-literature
| S-EPMC5510189 | biostudies-literature
| S-ECPF-GEOD-32967 | biostudies-other
| S-EPMC3538912 | biostudies-literature
| S-EPMC4862436 | biostudies-other